Privia Health Group (NASDAQ:PRVA) CFO David Mountcastle Sells 24,734 Shares of Stock

Privia Health Group, Inc. (NASDAQ:PRVA) CFO David Mountcastle sold 24,734 shares of the firm’s stock in a transaction on Thursday, July 2nd. The shares were sold at an average price of $27.50, for a total value of $680,185.00. Following the sale, the chief financial officer directly owned 186,728 shares of the company’s stock, valued at $5,135,020. This represents a 11.70% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

David Mountcastle also recently made the following trade(s):

• On Friday, June 26th, David Mountcastle sold 17,196 shares of Privia Health Group stock. The shares were sold at an average price of $25.18, for a total transaction of $432,995.28.
• On Monday, May 11th, David Mountcastle sold 3,385 shares of Privia Health Group stock. The stock was sold at an average price of $22.60, for a total transaction of $76,501.00.
• On Monday, May 4th, David Mountcastle sold 1,206 shares of Privia Health Group stock. The stock was sold at an average price of $25.00, for a total transaction of $30,150.00.
• On Friday, May 1st, David Mountcastle sold 7,179 shares of Privia Health Group stock. The shares were sold at an average price of $25.03, for a total transaction of $179,690.37.

Privia Health Group Price Performance

Privia Health Group stock traded up $0.04 during trading hours on Tuesday, hitting $27.23. The company had a trading volume of 1,077,240 shares, compared to its average volume of 934,312. The firm has a 50-day moving average of $23.53 and a 200 day moving average of $23.04. The firm has a market cap of $3.43 billion, a PE ratio of 170.20, a PEG ratio of 2.16 and a beta of 0.83. Privia Health Group, Inc. has a one year low of $18.77 and a one year high of $27.70.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on PRVA. Weiss Ratings raised Privia Health Group from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday. Barclays lowered their price objective on Privia Health Group from $25.00 to $24.00 and set an “equal weight” rating on the stock in a research report on Tuesday, May 26th. Canaccord Genuity Group dropped their target price on Privia Health Group from $35.00 to $34.00 and set a “buy” rating for the company in a report on Friday, May 8th. Finally, Evercore set a $26.00 price target on shares of Privia Health Group in a research note on Wednesday, April 8th. Eleven investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $31.15.

Hedge Funds Weigh In On Privia Health Group

Hedge funds have recently added to or reduced their stakes in the stock. GAMMA Investing LLC raised its holdings in Privia Health Group by 14.0% in the 2nd quarter. GAMMA Investing LLC now owns 4,819 shares of the company’s stock valued at $124,000 after acquiring an additional 592 shares in the last quarter. State of Alaska Department of Revenue increased its position in shares of Privia Health Group by 1.3% in the fourth quarter. State of Alaska Department of Revenue now owns 65,747 shares of the company’s stock worth $1,558,000 after purchasing an additional 823 shares during the period. PNC Financial Services Group Inc. raised its stake in Privia Health Group by 8.8% in the first quarter. PNC Financial Services Group Inc. now owns 10,361 shares of the company’s stock valued at $213,000 after purchasing an additional 840 shares in the last quarter. ProShare Advisors LLC lifted its position in Privia Health Group by 4.1% during the fourth quarter. ProShare Advisors LLC now owns 22,576 shares of the company’s stock worth $535,000 after purchasing an additional 898 shares during the period. Finally, Vanguard Personalized Indexing Management LLC lifted its position in Privia Health Group by 5.9% during the fourth quarter. Vanguard Personalized Indexing Management LLC now owns 16,250 shares of the company’s stock worth $385,000 after purchasing an additional 903 shares during the period. Institutional investors own 94.48% of the company’s stock.

About Privia Health Group

Privia Health Group (NASDAQ: PRVA) is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.